The use of antiviral compounds in analyzing the sequential steps in the replication of SV40 papovavirus.
D000256:Adenoviridae / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D003168:Complement Fixation Tests; D003561:Cytarabine / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005472:Fluorouracil / Q000494:pharmacology*; D007065:Idoxuridine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008937:Mitomycins / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D013539:Simian virus 40 / Q000254:growth & development*
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D008937:Mitomycins; D003561:Cytarabine; D003609:Dactinomycin; D010649:Phenylalanine; D011691:Puromycin; D007065:Idoxuridine; D005472:Fluorouracil